TAUNS Laboratories, Inc.
197A.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥4,609,929 | ¥9,266,630 | ¥8,580,850 | ¥7,573,438 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥2,315,071 | ¥247,777 | ¥4,975,283 | ¥6,793,110 |
| Inventory | ¥6,811,567 | ¥5,883,526 | ¥5,014,206 | ¥5,003,711 |
| Other Curr. Assets | ¥1,126,908 | ¥50,075 | ¥183,550 | ¥198,170 |
| Total Curr. Assets | ¥14,863,475 | ¥15,476,605 | ¥18,753,889 | ¥19,568,429 |
| Property Plant & Equip (Net) | ¥15,464,810 | ¥12,279,213 | ¥12,151,860 | ¥11,768,005 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥3,841,746 | ¥3,865,660 | ¥3,865,660 | ¥3,827,924 |
| Long-Term Investments | ¥4,177,015 | ¥4,889,440 | ¥2,863,723 | ¥848,178 |
| Tax Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Assets | ¥737,017 | ¥4,376 | ¥2 | ¥2 |
| Total NC Assets | ¥24,220,588 | ¥21,038,689 | ¥18,881,245 | ¥16,444,109 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥39,084,063 | ¥36,515,294 | ¥37,635,134 | ¥36,012,538 |
| Liabilities | – | – | – | – |
| Payables | ¥1,298,136 | ¥1,199,041 | ¥1,296,994 | ¥1,348,476 |
| Short-Term Debt | ¥6,195,223 | ¥5,614,919 | ¥5,331,996 | ¥5,232,000 |
| Tax Payable | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Revenue | ¥0 | ¥78,606 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥1,577,959 | ¥1,623,616 | ¥2,442,847 | ¥2,186,566 |
| Total Curr. Liab. | ¥9,487,958 | ¥9,529,874 | ¥10,849,679 | ¥10,820,049 |
| LT Debt | ¥13,313,880 | ¥8,809,081 | ¥8,300,004 | ¥8,083,000 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥556,100 | ¥556,304 | ¥620,229 | ¥619,072 |
| Other NC Liab. | ¥207,740 | ¥202,363 | ¥193,171 | ¥199,272 |
| Total NC Liab. | ¥14,077,720 | ¥9,567,748 | ¥9,113,404 | ¥8,901,344 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥23,565,678 | ¥19,097,622 | ¥19,963,083 | ¥19,721,393 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥296,353 | ¥289,771 | ¥271,730 | ¥253,546 |
| Retained Earnings | ¥12,399,621 | ¥14,307,551 | ¥14,637,642 | ¥13,289,728 |
| AOCI | ¥42,754 | ¥39,362 | ¥7,646 | -¥2,847 |
| Other Equity | ¥2 | ¥7,915 | ¥2 | ¥13,870 |
| Total Equity | ¥15,518,383 | ¥17,417,670 | ¥17,672,050 | ¥16,291,143 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥39,084,061 | ¥36,515,294 | ¥37,635,133 | ¥36,012,536 |
| Net Debt | ¥14,899,174 | ¥5,157,370 | ¥5,051,150 | ¥5,741,562 |